Safety, pharmacokinetics and pharmacodynamics of BI 655064 in phase 1 clinical trials in healthy Chinese and Japanese subjects

AIMS: To evaluate the safety, pharmacokinetics and pharmacodynamics of BI 655064 in healthy Chinese and Japanese subjects after administration of single doses of 80‐240 mg and multiple dosing of 240 mg once weekly over 4 weeks. METHODS: Two phase 1, double‐blind, placebo‐controlled studies were cond...

Descripción completa

Detalles Bibliográficos
Autores principales: Tsuda, Yasuhiro, Grimaldi, Christine, Huang, Fenglei, Benediktus, Ewald, Yagi, Nobutaka, Padula, Steven J., Jang, In‐Jin, Steffgen, Jürgen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8056730/
https://www.ncbi.nlm.nih.gov/pubmed/33047859
http://dx.doi.org/10.1111/bcp.14601

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8056730/
https://www.ncbi.nlm.nih.gov/pubmed/33047859
http://dx.doi.org/10.1111/bcp.14601

Ejemplares similares